Investments and investor services
IPO Roundup: Fintech lender GreenSky, 7 more companies pricing shares this week
Online lender GreenSky offers quick decisions on home improvement loans and will trade on Nasdaq with ticker 'GSKY'
Company
NYSE:PFE
Pfizer Inc is a research-based biopharmaceutical company. The company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operates through two segments: Biopharma and PC1.
293 stories · page 10 of 15
Investments and investor services
Online lender GreenSky offers quick decisions on home improvement loans and will trade on Nasdaq with ticker 'GSKY'
Drug giant also was dinged by loss last December of exclusivity of Viagra in the US
Investments and investor services
Generally speaking, it has been a good earnings season so far for US companies, but a couple of disappointing announcements have scared investors who are already a little twitchy
Has the Japanese drugs giant sweetened further the cash element of its £43bn offer?
Next week we'll see the colour of Takeda's money. Will rival bidders emerge from the woodwork?
Reckitt Benckiser reported a 2% increase in like-for-like revenue in the first quarter
Archive
Reckitt Benckiser will report organic sales growth of 2.8% in the first quarter, UBS estimates
Archive
Week Ahead includes trading statements from Primark owner Associated British Foods, Debenhams, and JD Sports, plus Q1 numbers from Unilever, Reckitt Benckiser and Rentokil Initial
New York pharma giant is also working with Harvard researchers to develop fibrotic disease treatments
AirSonea device connects to a smartphone app to detect and measure wheeze.
The company is developing BTX 1204, a new treatment for eczema.
Deal would include Chapstick lip balm and Centrum vitamins
The news comes just days after GSK bowed out of the race to take over the consumer healthcare unit of Pfizer
Spending bill signed by Trump failed to lift market sentiment
After a sharp plunge in the markets on Thursday, Proactive takes a pre-market peek into the movers and shakers in New York
“An acquisition for the whole Pfizer consumer health business did not fit our acquisition criteria," said Reckitt boss Rakesh Kapoor
PF-04958242 helps the central nervous system to send and receive ‘messages’, and Biogen is looking to take it through Phase IIb trials later this year
Shares in Reckitt have continued to decline after Monday's disappointing results as JP Morgan cut its 2018 earnings guidance and target price
The group returned to like-for-like revenue growth in the fourth quarter..
It’s the second time regulators have given the thumbs-down to Vitaros, with the FDA flagging concerns over one of the ingredients in the cream as well as with the manufacturing process